SCHEMBL945139

SCHEMBL945139

COc1ccc(C2(C3CCCCCC3)N=C(C)C(=S)N2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 4/20 0.42
LMNA P02545 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SLC6A4 P31645 4/20 0.40
SLC6A3 Q01959 3/20 0.40
SLC6A2 P23975 1/20 0.40
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
CTSE P14091 1/20 0.39
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL945955 1.00 BACE1 (0.42) BACE1LMNAALDH1A1HPGDALOX15
SCHEMBL932692 1.00 BACE1 (0.42) BACE1LMNAALDH1A1HPGDALOX15
SCHEMBL6891601 0.85 BACE1 (0.35) BACE1LMNAALDH1A1HPGDALOX15
SCHEMBL945923 0.74 ALDH1A1 (0.39) LMNAALDH1A1MEN1KMT2AMAPT
SCHEMBL931327 0.68 BACE1 (0.53) BACE1SLC6A4SLC6A3SLC6A2CYP3A4
SCHEMBL931861 0.68 BACE1 (0.53) BACE1SLC6A4SLC6A3SLC6A2CYP3A4
SCHEMBL932399 0.68 BACE1 (0.53) BACE1SLC6A4SLC6A3SLC6A2CYP3A4
SCHEMBL945249 0.68 CHRNA1 (0.37) BACE1ALDH1A1HSD17B10SLC6A4SLC6A3
SCHEMBL16108921 0.61 BACE1 (0.55) BACE1LMNAALDH1A1HPGDALOX15
SCHEMBL4599181 0.60 BACE1 (0.46) BACE1TSHRSLC6A4SLC6A3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed